(Q46147831)

19 December 2017

title

The oxysterol receptor LXR inhibits proliferation of human breast cancer cells (English)

1 reference

19 December 2017

author

Sebastian A Lewandowski

2

1 reference

19 December 2017

Knut R Steffensen

5

1 reference

19 December 2017

Jan-Åke Gustafsson

4

object named as

Jan-Ake Gustafsson

1 reference

19 December 2017

Lise-Lotte Vedin

1

1 reference

19 December 2017

Paolo Parini

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

23 January 2009

1 reference

19 December 2017

published in

Carcinogenesis

1 reference

19 December 2017

volume

30

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

575-579

1 reference

19 December 2017

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Role of LXRs in control of lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Accumulation of foam cells in liver X receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Increased lipogenesis in cancer cells: new players, novel targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Regulation of 17beta-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5alpha-dihydrotestosterone in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic acid hydrochloride (GW3965).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

The Rb/E2F pathway: expanding roles and emerging paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP029

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGP029

1 reference

19 December 2017

PubMed ID

19168586

1 reference

19 December 2017